Sophie C. Morse

Sophie C. Morse

Auto-generated profile, based on publicly available information

Sophie C. Morse

Department of Emergency Medicine, University of Washington, Seattle, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2022 in Cureus
Verified
Journal Article
Open access
GMGabriel Morales
Gabriel Morales
AAAdeyinka Adedipe
Adeyinka Adedipe
SMSophie Morse
Sophie Morse
JMJames McCabe
James McCabe
CMClaudius Mahr
Claudius Mahr
GNGraham Nichol
Graham Nichol
Background Cardiogenic shock (CS) is critical end-organ hypoperfusion due to reduced cardiac output. Early therapy, such as vasoactive agents or the initiation of mechanical circulatory support (MCS), requires early diagnosis and is associated with better outcomes. A novel ultrasound platform (GE Healthcare, Milwaukee, WI) has semi- automated imaging software (SAIS), which could simplify the point-of-care ultrasound (POCUS) diagnosis of CS. We assessed the feasibility of using POCUS with SAIS in patients in shock, determined the ability of SAIS to identify the subset of patients with CS, and described the process and outcome of care of patients with vs. without CS after presenting to Emergency Department (ED) with hypotension. Methods This prospective case-control study was conducted at an urban ED. Physicians with prior POCUS education received one hour of training with the study device. The qualitative ejection fraction was determined by visual assessment. SAIS measurements of hemodynamics were made with the study device and included left ventricle outflow tract velocity time integral (LVOT VTI), inferior vena cava collapsibility or distensibility indices, and pulmonary B- line assessment. ED patients with a systolic blood pressure = 90 mmHg or need for a vasopressor initiation in the ED were enrolled. The diagnosis of CS was determined by a medical record review. All data were summarized descriptively. Results Twenty-nine cases underwent POCUS, and 87 controls did not. Baseline characteristics, process, and outcome of care were similar between groups. Seventy-nine percent ( 79%) of cases had a complete POCUS with SAIS. Of these, 55% had reduced LVOT VTI, 38% had IVC collapsibility <50%, and 48% of cases had a B-line pattern consistent with pulmonary edema. The mean LVOT VTI for cases with CS was 9.4 +/- 5.4 cm; the mean LVOT VTI for cases without CS was 15.2 +/- 6.0 cm. Among patients who did not undergo POCUS, 31 (36%) had a formal echocardiogram, and eight (9%) had a final diagnosis of cardiogenic shock during hospitalization. Conclusion Physicians with one hour of platform-specific training were able to implement POCUS with SAIS among patients who present with shock. POCUS with SAIS may aid in the early recognition of CS.

24 November 2021 in Journal of Substance Abuse Treatment
Verified
Journal Article
Closed access
LWLauren K. Whiteside
Lauren K. Whiteside
LHLy Huynh
Ly Huynh
SMSophie Morse
Sophie Morse
JHJane Hall
Jane Hall
WMWilliam Meurer
William Meurer
DZDouglas F. Zatzick
Douglas F. Zatzick

28 April 2023 in International Journal of Emergency Medicine
Verified
Journal Article
Open access
PDF file
SMSophie C. Morse
Sophie C. Morse
CFCallan Fockele
Callan Fockele
LHLy Ngoc Huynh
Ly Ngoc Huynh
AZAlina Zatzick
Alina Zatzick
LWLauren Kirsten Whiteside
Lauren Kirsten Whiteside
Background: Morbidity and mortality rates related to methamphetamine are on the rise. Simultaneously, social-distancing guidelines were issued in March 2020 to decrease transmission of COVID-19. The aim of this study was to explore concerns regarding methamphetamine use during the COVID-19 pandemic and subsequent harm reduction strategies with patients who use methamphetamine to inform emergency department (ED)-based harm reduction approaches. Methods: A mixed-methods study of adults residing in Washington with high-risk methamphetamine use and a recent ED visit from April-September 2020 was performed. Participants completed a survey and a semi-structured interview on perceptions and experiences of COVID-19. Descriptive statistics were used for survey responses. Interview transcripts were analyzed and guided by modified grounded theory using an iterative approach to refine the guide and codebook. Interviews were independently coded by 2 investigators and discussed until consensus. Results: Twenty-five participants completed the survey; 20 participants were interviewed (45% recently used heroin, 40% unstably housed). Thirty-five percent was worried about COVID-19 infection. Three themes emerged from the interviews: (1) increase in meth use, (2) interplay of meth obtention and COVID-19, and (3) interactions with healthcare and social services. Conclusions: People who use methamphetamine noted an increase in use along with the social distancing guidelines put in place for COVID-19 and employed a variety of harm reduction profiles when obtaining methamphetamine. Also, the pandemic brought difficulties in accessing care and amplified mistrust in healthcare instructions and public health messages. Based on these qualitative interviews, further work should consider aligning methamphetamine and COVID-19 harm reduction messages and working with trusted community resources to improve harm reduction strategies for methamphetamine use and COVID-19. IRB: Informed Consent by the University of Washington Human Subjects Division (approval number, STUDY00009277).

1 August 2021 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
JLJacob A. Lebin
Jacob A. Lebin
LHLy Huynh
Ly Huynh
SMSophie C. Morse
Sophie C. Morse
KJKarl Jablonowksi
Karl Jablonowksi
JHJane Hall
Jane Hall
LWLauren K. Whiteside
Lauren K. Whiteside